beyfortus
astrazeneca ab - nirsevimab - imuninės serumai ir imunoglobulinai, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.
furosemide ibe
ibe pharma, uab - furozemidas - injekcinis ar infuzinis tirpalas - 10 mg/ml - furosemide
lasix
tamro, uab - furozemidas - injekcinis tirpalas - 20 mg/2 ml - furosemide
lasix retard
niromed, uab - furozemidas - pailginto atpalaidavimo kietosios kapsulės - 60 mg - furosemide
amaryl
limedika, uab - glimepiridas - tabletės - 3 mg; 2 mg - glimepiride
cordarone
sanofi winthrop industrie - amjodarono hidrochloridas - tabletės - 50 mg/ml; 200 mg - amiodarone
depakine chronosphere
sanofi winthrop industrie - natrio valproatas - modifikuoto atpalaidavimo granulės - 750 mg; 500 mg; 250 mg; 1000 mg - valproic acid
essentiale forte n
opella healthcare france sas - sojų fosfolipidai - kietosios kapsulės - 600 mg; 300 mg - phospholipids
granocyte 34
sanofi-aventis groupe - lenograstimas - milteliai ir tirpiklis injekciniam ar infuziniam tirpalui - 33,6 mln. tv/ml; 33,6 mtv/ml - lenograstim
heparoid
sanofi-aventis lietuva, uab - heparinoidas - kremas - 2 mg/g - organo-heparinoid